It’s great to read such knowledgeable commentary on this board, looking at things from so many different angles. The Q3 report looked good to my eyes, too. The future looks promising as well, if the forecast from Silmäasema’s CEO comes true: “Oculomics will lead affordable and scalable population-wide screening”. The post also promises that their pilot has been completed and that we’ll hear more about it soon.
I think there was also some speculation on this board at some point that Optomed might be involved in this pilot. And indeed, looking at the pilot lead’s posts, there are links to Optomed. Roche also flashes by in one of the pictures.